Badger Meter (BMI): Recent +5.6% Rebound Amid Quarterly Pressure and Key Earnings Ahead
Key Takeaways
- Badger Meter (BMI) stock rose approximately +5.6% over the past 30 days, rebounding from lows around $147 to recent closes near $155, driven by analyst upgrades and expanded share repurchases.
- Over the past quarter, the stock declined -10% from around $171 to $155, reflecting pressure from a Q4 2025 earnings miss on revenue despite EPS growth.
- Positive factors include Baird's upgrade to Outperform, resilient demand for smart water solutions, and SmartCover product momentum.
- Broader challenges encompass decelerating organic growth, cautious municipal spending, and sector rotation away from high-valuation industrials.
- Upcoming Q1 2026 earnings on April 17 will be key, with focus on sales acceleration and margins.
Understanding Badger Meter (BMI) and Its Place in the Market
Badger Meter, Inc. (BMI) stands out as a leading provider of flow measurement, water quality, and control products, serving water utilities, municipalities, and industrial customers. The company produces smart water meters, ultrasonic metering systems, valves, and analytics software like BEACON and AquaCUE, which help enable efficient water management through data-driven insights.
At its core, the business model centers on the "BlueEdge" suite, blending hardware such as meters and sensors with SaaS platforms for network monitoring and anomaly detection. Nearly 95% of sales are water-related, with two-thirds coming from utility smart-metering systems.
In the $4.6 billion smart water metering industry—projected to reach $13.1 billion by 2034—Badger Meter maintains a strong North American position with about 15-18% market share, competing with names like Itron and Sensus (Xylem). From what I see, its advancements in cellular IoT, ultrasonic technology, and vertical integration drive premium margins around 42% gross, along with recurring revenue from software, which has helped the stock show resilience despite swings tied to execution and broader utility spending trends.
BMI Stock Performance: 30-Day Gains Versus Quarterly Decline
Looking at the last 30 days, BMI stock climbed +5.6%, moving from a close of $147.20 on March 10, 2026, to $155.41 on April 9, 2026. The path was volatile but trended upward, with lows near $144 in mid-March yielding to gains above $156 in early April, signaling a shift in sentiment.
Over the past quarter, however, shares fell -10%, sliding from $171.19 on January 12, 2026 (close to quarter-ago levels), into the current $155 range. This range-bound to downward pattern followed post-earnings pressure in late January, featuring some rebounds but an inability to break back above $160 amid wider market shifts.
Drivers Behind the Recent 30-Day Uptick in BMI
The 30-day recovery was fueled by analyst optimism and company moves. Baird upgraded BMI to Outperform from Neutral on March 30, 2026, lifting its price target to $173 from $165, based on appealing valuation, growth prospects, and minimal geopolitical risks. This helped spark the rebound from March lows.
Insider buying and a new $150 million share repurchase program through 2028 further underscored management's confidence, lifting investor sentiment. Strong SmartCover sales and margin gains from cost discipline helped counter prior softness. Water infrastructure tailwinds, including steady demand for utility replacements, aided the move, even as daily swings continued and the stock trailed broader indices at times.
What Led to BMI's Quarterly Performance
The quarter's decline was largely shaped by the January 28, 2026, Q4 2025 earnings report, where revenue hit $220.7 million, up 8% year-over-year but 4.9% below estimates ($10.9 million short). EPS came in at $1.14, topping the prior year but edging past consensus slightly, prompting an 11% plunge to $146.
Organic growth eased to 2%, missing hopes, due to delays in advanced metering infrastructure (AMI) projects and restrained municipal budgets. Broader pressures like tighter credit and waning federal funds (such as ARPA) weighed on utility capital spending. Rotation by institutions away from high-PE industrials toward cheaper cyclicals added to the downside, with BMI lagging the S&P 500. On the positive side, operating margins held steady at 19.5% and free cash flow reached records, though revenue worries overshadowed these.
Trending AI Robots
I’ve found Trending AI Robots on Tickeron particularly useful in my own analysis—it highlights the platform's top-performing AI trading bots out of hundreds, which scan and trade thousands of tickers across markets. These bots use varied approaches like trend-following, mean reversion, or momentum across intraday, swing, or long-term trades, with clear metrics such as win rate, profit factor, and Sharpe ratio. Curated by recent performance and market fit—like handling volatility in industrials or utilities—it’s a practical way to spot bots that align with current conditions and add data-driven automation to my workflow.
What to Watch for BMI's Outlook Moving Forward
One thing that stands out is the Q1 2026 earnings on April 17, 2026—I'm watching closely for signs of revenue acceleration, AMI project progress, and guidance, especially with an anticipated EPS dip. Trends in smart water adoption, such as ultrasonic meter transitions and IoT integration, will remain crucial.
The macro backdrop matters too: interest rates affecting utility borrowing, inflation on costs, and regulations around water sustainability could sway demand. I also checked this using Tickeron’s AI Screener to gauge how BMI stacks up against industry peers.
Risks involve more capex delays or competitive pressures; potential catalysts include buyback progress, analyst updates, and any return of sector interest to growth stocks like this one.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BMI in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 10, 2026
BMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 37 cases where BMI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 69 cases where BMI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
Following a +1.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 185 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMI as a result. In 60 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 30 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
BMI moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
The Aroon Indicator for BMI entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.371) is normal, around the industry mean (4.255). P/E Ratio (29.632) is within average values for comparable stocks, (88.653). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.013) settles around the average of (0.004) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. BMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments
Advertisement